System, device and method for high-throughput multi-plexed detection
US-9188586-B2 · Nov 17, 2015 · US
US9506917B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9506917-B2 |
| Application number | US-201514629164-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 23, 2015 |
| Priority date | Aug 24, 2012 |
| Publication date | Nov 29, 2016 |
| Grant date | Nov 29, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a system, device, and method for the high throughput multiplexed detection of a wide number of compounds. The invention comprises of a microwell array coupled to a capture agent array to form a plurality of interfaces between a microwell and a set of immobilized capture agents. The set of capture agents comprises a plurality of distinguishable features, with each feature corresponding to the detection of a particular compound of interest. In certain embodiments, each microwell is configured to contain a single cell. The invention is therefore capable of performing a high throughput analysis of single cell profiles, including profiles of secreted compounds.
Opening claim text (preview).
What is claimed: 1. A device for multiplexed detection of compounds secreted from a cell, the device comprising: a plurality of enclosed interfaces, wherein each enclosed interface comprises (a) a microchamber configured to contain a cell and (b) a substrate containing at least ten spatially identifiable isolated features, wherein at least ten of the isolated features contain at least two immobilized capture antibodies per isolated feature, and wherein each immobilized capture antibody recognizes a different protein of interest. 2. The device of claim 1 , wherein at least ten of the isolated features contain at least three immobilized capture antibodies per isolated feature. 3. The device of claim 1 , wherein the enclosed interfaces are arranged in parallel. 4. The device of claim 1 , wherein the isolated features are arranged in parallel within the enclosed interfaces. 5. The device of claim 1 , wherein the device comprises 200 microchambers per cm 2 to 20,000 microchambers per cm 2 . 6. The device of claim 1 , wherein the device comprises 100 microchambers to 100,000 microchambers. 7. The device of claim 1 , wherein at least one of the isolated features on the substrate comprises 5 to 100 different capture antibodies. 8. The device of claim 1 , wherein each microchamber has a length of 100 μm to 2000 μm, a width of 10 μm to 100 μm, and a depth of 10 μm to 100 μm. 9. The device of claim 1 , wherein each isolated feature has a width of 5 μm to 50 μm. 10. The device of claim 1 , wherein the isolated features are separated from each other by 5 μm to 50 μm. 11. The device of claim 1 , wherein each of the isolated features contains at least three immobilized capture antibodies. 12. The device of claim 1 , wherein the isolated feature is a microchannel. 13. The device of claim 1 , wherein the isolated features are fabricated by a cross-flow patterning technique. 14. The device of claim 1 , wherein the isolated features are fabricated by a micro-scale printing technique. 15. The device of claim 14 , wherein the micro-scale printing technique is microspotting or inkjet printing. 16. The device of claim 1 , wherein the device comprises at least one cell within a microchamber of at least one enclosed interface. 17. The device of claim 16 , wherein the microchamber comprises proteins secreted from the at least one cell. 18. The device of claim 17 , wherein the proteins are bound to capture antibodies of isolated features of the substrate.
Solid-phase reaction mechanisms · CPC title
Apparatus specially adapted for solid-phase testing · CPC title
Cancer · CPC title
Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes · CPC title
Analytical elements · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.